Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
HRS-4729 is the earlier-stage triple-agonist backup within that portfolio
Document thoroughly
Do not use retatrutide if you have: Personal or family history of medullary thyroid carcinoma Multiple Endocrine Neoplasia syndrome type 2 History of pancreatitis Severe gastroparesis or other serious GI motility disorders Known hypersensitivity to any component of the drug Use with caution and close monitoring if you have: Existing cardiovascular disease, given the heart rate increase Gallbladder disease or a history of gallstones Kidney disease, as dehydration from GI side effects can worsen kidney function Type 1 diabetes or insulin-dependent Type 2 diabetes A history of eating disorders, as extreme appetite suppression can interact with disordered eating patterns in unpredictable ways Pregnancy is an absolute contraindication
It has been studied extensively as a research tool for investigating central amylin receptor signaling, energy homeostasis regulation, and glycemic modulation in preclinical metabolic models
US$ 23.86
US$ 24.99
US$ 24.37
US$ 20.51
US$ 29.17
